Association of eating disorders with catechol-O-methyltransferase gene functional polymorphism

Neuropsychobiology

Volumn 54, Issue 1, 2006, Pages 82-86

  Mikołajczyk, Elzbieta ^a   Śmiarowska, Małgorzata ^a   Grzywacz, Anna ^a   Samochowiec, Jerzy ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Anorexia; Bulimia; Catechol O methyltransferase; Eating disorders

Indexed keywords

CATECHOL METHYLTRANSFERASE; CATECHOLAMINE;

ADULT; ALLELE; ANOREXIA NERVOSA; ARTICLE; BULIMIA; CATECHOLAMINE METABOLISM; CODON; CONTROLLED STUDY; DISEASE SEVERITY; EATING DISORDER; ENZYME ACTIVITY; ENZYME ASSAY; EQUILIBRIUM CONSTANT; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; EATING DISORDERS; EXONS; FEMALE; GENE FREQUENCY; HUMANS; POLYMORPHISM, GENETIC;

EID: 33750729945     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096043     Document Type: Article

References (26)

1. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL: Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 2006;63:305-312.
2. Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L: The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991;148:1627-1637.
3. Weinshilboum RM, Otterness DM, Szumlanski CL: Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999;39:19-52.
4. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Wein-shilboum RM: Human catechol-O-methyltransferase pharmaco-genetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243-250.
5. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D: COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240-1243.
6. Frisch A, Laufer N, Danziger Y, Michaelovsky E, Leor S, Carel C, Stein D, Fenig S, Mimouni M, Apter A, Weizman A: Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients. Mol Psychiatry 2001;6:243-245.
7. Gabrovsek M, Brecelj-Anderluh M, Bellodi L, Cellini E, Di Bella D, Estivill X, Fernandez-Aranda F, et al: Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet 2004;124:68-72.
8. Michaelovsky E, Frisch A, Leor S, Stein D, Danziger Y, Carel C, Fennig S, Mimouni M, Klauck SM, Benner A, Poustka A, Apter A, Weizman A: Haplotype analysis of the COMT-ARVCF gene region in Israeli anorexia nervosa family trios. Am J Med 2005;139:45-50.
9. Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D: Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology 2001;26:393-409.
10. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ: Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 1998;55:927-935.
11. World Health Organization: International Classification of Diseases: Clinical Descriptions and Diagnostic Guidelines, 10th rev. Geneva, WHO, 1992.
12. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, 10th rev. Geneva, WHO, 1998.
13. Spitzer RL, Kroenke K, Williams J: Validation and utility of a self-report version of PRIME-MD. JAMA 1999;282:1737-1744.
14. SPSS for Windows, version 9.0. Asbach, RzK GmbH, 1999.
15. SAS Institute: SAS/STST User's Guide, release 6.03. Cary, SAS Institute, 1988.
16. UCLA Department of Statistics: Power Calculator. www.calculators.stat. ucla.edu/powercalc.
17. Garfinkel PE, Moldofsky H, Garner DM: The heterogeneity of anorexia nervosa: bulimia as a distinct subgroup. Arch Gen Psychiatry 1980;37:1036-1040.
18. Eckert ED, Halmi KA, Marchi P, Grove W, Crosby R: Ten-year follow-up of anorexia nervosa: clinical course and outcome. Psychol Med 1995;25:143-156.
19. Bulik CM, Tozzi F: The genetics of bulimia nervosa. Drugs Today 2004;40:741-749.
20. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D: A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002;159:652-654.
21. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG: Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci 2005;17:1018-1025.
22. Kerem NC, Katzman DK: Brain structure and function in adolescents with anorexia nervosa. Adolesc Med 2003;14:109-118.
23. Ham BJ, Lee MS, Lee YM, Kim MK, Choi MJ, Oh KS, Jung HY, Lyoo IK, Choi IG: Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia. Neuropsychobiology 2005;52:151-154.
24. Kessler H, Schwarze M, Filipic S, Traue HC, von Wietersheim J: Alexithymia and facial emotion recognition in patients with eating disorders. Int J Eat Disord 2006;39:245-251.
25. Thapar A, Langley K, Fowler T, Rice F, Turic D, Whittinger N, Aggleton J, Van den Bree M, Owen M, O'Donovan M: Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2005;62:1275-1278.
26. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I: Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 2004;161:1703-1705.